Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
The Journal of Pharmacy and Pharmacology|December 1, 1986
Antipyrine kinetics following partial blood exchange with Fluosol-DA in the ratR P Shrewsbury, S G White, G M Pollack, et al.Biochemical Pharmacology|August 23, 1996
Evidence for reversible sequestration of morphine in rat liverC J Matheny, D R Taft, K L Brouwer, et al.Pharmaceutical Research|May 20, 1998
Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the ratS P Letrent, G M Pollack, K R Brouwer, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the ratS P Letrent, G M Pollack, K R Brouwer, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1995
Comparative toxicokinetics of methanol in the female mouse and ratK W Ward, R A Perkins, J L Kawagoe, et al.Journal of Pharmaceutical Sciences|April 1, 1996
Age-related changes in valproic acid binding to rat serum proteins in vitroP W Slattum, A E Cato, G M Pollack, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1995
Age-dependent intestinal hydrolysis of valproate glucuronide in ratP W Slattum, A E Cato, G M Pollack, et al.Pharmacotherapy|July 11, 2001
Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulationC J Matheny, M W Lamb, K R Brouwer, et al.Toxicology and Applied Pharmacology|June 30, 1985
Effects of route of administration and repetitive dosing on the disposition kinetics of di(2-ethylhexyl) phthalate and its mono-de-esterified metabolite in ratsG M Pollack, R C Li, J C Ermer, et al.Life Sciences|February 9, 2000
Increased brain P-glycoprotein in morphine tolerant ratsC L Aquilante, S P Letrent, G M Pollack, et al.Pageof 9